Keywords: پلیپیل; Adherence; cardiovascular disease; polypill; secondary prevention;
مقالات ISI پلیپیل (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: پلیپیل; PolyPill; Multidrug delivery; Fixed dose combination; Patient compliance; Drug delivery and drug development;
Keywords: پلیپیل; Prevención secundaria cardiovascular; Policomprimido; Adherencia; Coste-efectividad; Secondary cardiovascular prevention; Polypill; Adherence; Cost-effectiveness; ACEI; angiotensin-converting enzyme inhibitors; NNT; number of patients needed to treat; QA
Keywords: پلیپیل; Hypertension; Low- and middle-income countries; Community engagement; mHealth; Task redistribution; Salt reduction; Salt substitution; Polypill;
Keywords: پلیپیل; Dual antiplatelet therapy; Interaction/degradation products; Physico-chemical characterization; Polypill; Preformulation; Ticagrelor; Solid-state;
Keywords: پلیپیل; Aspirin (PubChem CID: 2244); Hydrochlorothiazide (PubChem CID: 3639); Atenolol (PubChem CID: 2249); Pravastatin sodium (PubChem CID: 16759173); Ramipril (PubChem CID: 5362129); 3D printing; Polypill; Sustained release; Immediate release; Personalised medi
Polypill, hypertension and medication adherence: The solution strategy?
Keywords: پلیپیل; Adherence; Polypill; Hypertension; Systolic blood pressure; LDL-cholesterol; Cardiovascular events;
Impact of switching to polypill based therapy by baseline potency of medication: Post-hoc analysis of the SPACE Collaboration dataset
Keywords: پلیپیل; Polypill; Combination therapy; Cardiovascular prevention; Meta-analysis;
Stroke minimization through additive anti-atherosclerotic agents in routine treatment (SMAART): A pilot trial concept for improving stroke outcomes in sub-Saharan Africa
Keywords: پلیپیل; Africa; Atherosclerosis; Polypill; Secondary prevention; Stroke;
ArtÃculo originalUtilidad de un policomprimido cardiovascular en el tratamiento de pacientes en prevención secundaria en España: un estudio de coste-efectividadUsefulness of a Cardiovascular Polypill in the Treatment of Secondary Prevention Pati
Keywords: پلیپیل; Prevención secundaria cardiovascular; Policomprimido; Adherencia; Coste-efectividad; Secondary cardiovascular prevention; Polypill; Adherence; Cost-effectiveness; AAS; ácido acetilsalicÃlico; AVAC; año de vida ajustado por calidad; IECA; inhibidores d
Application of an LC-MS/MS method for the analysis of amlodipine, valsartan and hydrochlorothiazide in polypill for a bioequivalence study
Keywords: پلیپیل; Amlodipine; Valsartan; Hydrochlorothiazide; LC-MS/MS; Polypill; Bioequivalence;
Variabilidad interhospitalaria en la prescripción tras un sÃndrome coronario agudo: hallazgos del estudio ACDC
Keywords: پلیپیل; SÃndrome coronario agudo; Policomprimido; Variabilidad de prescripción; Acute coronary syndrome; Polypill; Variability in prescribing; CCI; coeficiente de correlación intraclase; ICr; intervalo de credibilidad; IECA; inhibidores de la enzima de convers
Interhospital Variability in Drug Prescription After Acute Coronary Syndrome: Insights From the ACDC Study
Keywords: پلیپیل; Acute coronary syndrome; Polypill; Variability in prescribingSíndrome coronario agudo; Policomprimido; Variabilidad de prescripciónACS, acute coronary syndrome; ACE, angiotensin-converting enzyme; CrI, credibility interval; ICC, intraclass correlation coe
Effectiveness of fixed dose combination medication (‘polypills’) compared with usual care in patients with cardiovascular disease or at high risk: A prospective, individual patient data meta-analysis of 3140 patients in six countries
Keywords: پلیپیل; Meta-analysis; Polypill; Secondary prevention; Cardiovascular disease
Comparison of a morning polypill, evening polypill and individual pills on LDL-cholesterol, ambulatory blood pressure and adherence in high-risk patients; a randomized crossover trial
Keywords: پلیپیل; Polypill; Fixed-dose combination pill; Cardiovascular prevention; Aspirin; Statin; Bloodpressure lowering agent;
Simultaneous determination of amlodipine, valsartan and hydrochlorothiazide by LC–ESI-MS/MS and its application to pharmacokinetics in rats
Keywords: پلیپیل; Amlodipine; Valsartan; Hydrochlorothiazide; Exforge HCT; Polypill
A Polypill Strategy to Improve Global Secondary Cardiovascular Prevention : From Concept to Reality
Keywords: پلیپیل; cardiovascular disease; fixed-dose combination; global cardiovascular health; polypill; secondary preventionBP, blood pressure; CHD, coronary heart disease; CV, cardiovascular; CVD, cardiovascular disease; FDC, fixed-dose combination; LDL-C, low-density l
Polypill Therapy, Subclinical Atherosclerosis, and Cardiovascular Events—Implications for the Use of Preventive Pharmacotherapy : MESA (Multi-Ethnic Study of Atherosclerosis)
Keywords: پلیپیل; polypill; risk stratification; subclinical atherosclerosisCAC, coronary artery calcium; CHD, coronary heart disease; CVD, cardiovascular disease; FRS, Framingham risk score; HR, hazard ratio; NNT, number needed to treat
The Concept of the Polypill in the Prevention of Cardiovascular Disease
Keywords: پلیپیل; cardiovascular disease; polypill; prevention; public health
A Polypill Strategy to Improve Adherence : Results From the FOCUS Project
Keywords: پلیپیل; adherence; polypill; secondary preventionACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin-II receptor blocker; ASA, acetylsalicylic acid; BP, blood pressure; CV, cardiovascular; LDL-C, low-density lipoprotein cholesterol; LMIC, low- and mid
Prospective meta-analysis of trials comparing fixed dose combination based care with usual care in individuals at high cardiovascular risk: The SPACE Collaboration
Keywords: پلیپیل; Meta-analysis; Prospective; Polypill; Cardiovascular disease;
Un problema alarmante en prevención secundaria: bajo cumplimiento (estilo de vida) y baja adherencia (farmacológica)
Keywords: پلیپیل; CNIC, Centro Nacional de Investigación Cardiovascular; ECV, enfermedad cardiovascular; OMS, Organización Mundial de la SaludPrevención secundaria; Polipastilla; Adherencia; Estilo de vida; Cardiopatía isquémicaSecondary prevention; Polypill; Adherence; Li
La llamada polipill: ¿una solución o un problema?
Keywords: پلیپیل; Polypill; Combinación a dosis fijas; Prevención cardiovascular; Factores de riesgo; Polypill; Fixed-dose combination; Cardiovascular prevention; Risk factors;
Acceptance of a Polypill Approach to Prevent Cardiovascular Disease Among a Sample of U.S. Physicians
Keywords: پلیپیل; Polypill; Cardiovascular disease prevention; Physician acceptance;
Polypill and Global Cardiovascular Health Strategies
Keywords: پلیپیل; cardiovascular prevention; polypill; risk factors
Improving adherence using combination therapy (IMPACT): Design and protocol of a randomised controlled trial in primary care
Keywords: پلیپیل; CVD; Cardiovascular Disease; IMPACT; IMProving Adherence using Combination Therapy; LDLc; Low Density Lipoprotein cholesterol; RHP; Red Heart Pill; SAE; Serious Adverse Event; WHO; World Health Organisation; Polypill; Randomised controlled trial; Cardiova
Polypill for the treatment of cardiovascular diseases: Part 2. LC–MS/TOF characterization of interaction/degradation products of atenolol/lisinopril and aspirin, and mechanisms of formation thereof
Keywords: پلیپیل; CVD; Polypill; Interaction/degradation products; LC–MS/TOF; Fragmentation pathway; Accurate mass